Callouts & quotes from 26,677+ activist slides

"Target falls short vs. refining peers that are offering ~100% FCF"

"PHILLIPS FALLS SHORT OF BEST PRACTICES IN ATTEMPTING A TURNAROUND"

"The investment team is the right size and remains fully committed"

"Fortrea’s adjusted EBITDA margins are well below the peer median."

"Twist samples lacked the necessary uniformity and quality control"

"~$11 per share of value degradation...~45% of today's share price"

"Franchised business model is a capital-light, high-growth annuity"

"豊田自動織機の2026年3月期の営業利益ガイダンスは、為替の誤りおよび過度な保守性により、大幅かつ繰り返し過小に見積もられてきた。"

">35% Difference may point to further multiple compression to come"

"We are unclear why Celgene management is so bullish on fedratinib"

"1967 14% Sterling devaluation – Countered by +10% HKD revaluation"

"CP's pricing deficit vs. CN has persisted and remains substantial"

"Total return to shareholders including dividends: negative 18%(1)"

"We find that four of Tasmanian's products have been discontinued."

"We have a plan for creating significant shareholder value at GCP."

"GGP equity offers an enormous potential reward for the risk taken"

"Marathon management has failed to prove the case for integration."

"All of a sudden, one thread unravels this whole web of deception."

"We see enormous trapped value at Phillips 66. The Board does not."

"2020 compensation Adj. EBITDA target 29% BELOW Investor Day goal!"

"To the extent RINO has a reputation among steel mills, it is poor"

"Undervaluation gets reinforced and overvaluation gets reinforced."

"We Believe GFI Poses A Material Threat To WFG's Recruitment Goals"

"We see enormous trapped value at Phillips 66. The Board does not."

"Phillips 66's Baseline for Cost Reduction – conveniently elevated"

"CPI PG Agrees to Buy Metrogate House via a Same-Day Property Flip"

"Intentionally structured to avoid a pre-closing shareholder vote."

"「すみません。EUV関連装置の中の内訳は開示しておりません」「製品ごとに向け先などを区分けして情報はディスクローズしておりません」"

"収入を“積極的に”誇示する、あるいは費用を過少に計上するなどの小細工をした場合、結果的にいずれかの資産を誇大に計上することになる。"

"結局、ACTIS A300は投資家をごまかし、事実上の商品リコールを「新製品」として発表し、ダメージを最小限に抑えようとしたのだ。"

"ASMLのリンクインのプロフィールでは、同社のサイマー事業があるサンディエゴ大都市圏に1299名も配備してある、と記載されている。"

"TSMCは、レーザーテック製のACTIS装置が十分に機能しないので、KLA製などのバックアップ装置を保持しなければいけない状況だ。"

"Fortrea’s adjusted EBITDA margins are well below the peer median."

"Can a Company with Accounts this Inconsistent Really Manage Risk?"

"Franchised business model is a capital-light, high-growth annuity"

"Goldman forecasts a long-term supply gap starting in a few years."

"Borders is similar to other investments where we have had success"

"Ginkgo immediately booked $81.5mm of revenue and deferred revenue"

"大流行したリップモンスター製品の成功を足掛かりに、モンスターリップ型の特注リップケースを販売するというアイディアはどうでしょうか？"

"iPrefs are equity, not debt. There is no such thing as a default."

"It seems to us that if the deal breaks, the stock should recover."

"Fortrea’s adjusted EBITDA margins are well below the peer median."

"A stop order would effectively end any hopes of closing the deal."

"Zillow management is a liberal user of growth-oriented buzzwords."

"Target falls short vs. refining peers that are offering ~100% FCF"

"Management lacks refining experience; over-reliant on consultants"

"2024 performance more closely resembled the average S&P 500 stock"

"We See 20% - 50% Potential Downside Risk In Limbach’s Share Price"

"We See 20% - 50% Potential Downside Risk To Limbach's Stock Price"

"レーザーテックも早晩、同じ運命を辿るだろう。棚卸資産と利益を詐欺手段で誇大に計上した事実を認めて、厖大な減損処理を行うはめになる。"

"2023年11月にレーザーテックの次世代の極端紫外線マスク検査装置で将来の成長の牽引車として発表されたACTIS A300は偽物だ"

"Specialized Steel Capacity forecasted to grow by 24% through 2015"

"TransMedics “began to change the entirety of its business model.”"

"Organ performance on pump has no correlation with organ viability"

"TransMedics allegedly refusing to publish data on necrotic livers"

"We believe these steps can deliver up to 191p (1) to shareholders"

"We believe income investors will value FirstGroup US at a premium"

"What happened to the pro forma business being ~13% international?"

"Target will maintain its “A” category credit ratings at all times"

">The foreign clinical trials that led to FDA approval were a scam"